Nestin in multiple myeloma: emerging insights into a potential therapeutic target

Nestin in multiple myeloma: emerging insights into a potential therapeutic target

Multiple myeloma (MM) is the second most common hematological malignancy and remains incurable, with high rates of relapses and refractory. One of the root causes is the presence of multiple myeloma stem cells (MMSCs). The deficiency of MMSC treatment lies in the lack of specific targets. CD19, CD13...

Full description

Saved in:
Bibliographic Details
Main Authors: Yingmiao Wu, Ji Luo, Yue Zhou, Jiaoya Lin, Yajie Wu, Shuai Zheng, Jiao Chen, Feifei Che, Qiang Wang, Ling Zhong
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Oncology
Subjects:
nestin
multiple myeloma
multiple myeloma stem cells
cancer stem cells
therapeutic target
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1596928/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items